Neurotherapy for Chronic Fatigue Syndrome (ME/CFS)
DR. SURUCHI CHANDRA | NEUROTHERAPy
BETHESDA, MARYLAND I WASHINGTON DC
- Silva-Passadouro et al. (2024) — Systematic Review of qEEG Findings in ME/CFS, Fibromyalgia, and Long COVID https://pubmed.ncbi.nlm.nih.gov/
- Solve ME/CFS Initiative — Quantitative EEG Analyses in ME/CFS https://solvecfs.org
- Hammond DC (2001) — Treatment of Chronic Fatigue With Neurofeedback and Self-Hypnosis https://pubmed.ncbi.nlm.nih.gov/11642536/
Articles & Resources
About Dr. Chandra
Dr. Suruchi Chandra, MD, is a Harvard- and Yale-trained psychiatrist brings together emerging neuroscience-based therapies, trauma-informed care, nutritional approaches, and systems-level biology to advance thinking in psychiatry and help more patients find clearer paths forward.
See full bio.
Next Steps
Serving patients in Bethesda, Maryland, Washington DC, and Northern Virginia.
Medically reviewed by Suruchi Chandra, MD. This content is for educational purposes only and does not substitute for individualized medical advice.
Updated February 2026
Medically reviewed by Suruchi Chandra, MD. This content is for educational purposes only and does not substitute for individualized medical advice.
Updated February 2026
What qEEG Reveals About Brain Function in ME/CFS
Quantitative EEG (qEEG) is a functional assessment that measures brainwave activity and connectivity patterns. Unlike MRI or CT scans, which evaluate structure, qEEG provides insight into how the brain is functioning in real time.
Systematic reviews and clinical studies have identified qEEG abnormalities in ME/CFS and fibromyalgia, including:
qEEG does not diagnose ME/CFS. Instead, it offers objective information about brain network dysregulation, helping guide individualized neurotherapy approaches and monitor change over time.
Systematic reviews and clinical studies have identified qEEG abnormalities in ME/CFS and fibromyalgia, including:
- Dysregulation in frontal and temporal regions
- Altered connectivity within attention and default-mode networks
- Patterns associated with cognitive slowing, fatigue, and sensory sensitivity
qEEG does not diagnose ME/CFS. Instead, it offers objective information about brain network dysregulation, helping guide individualized neurotherapy approaches and monitor change over time.
Why Patients With ME/CFS in the DMV Consider Our Clinic
Our Bethesda clinic serves patients from Washington DC, Maryland, and Northern Virginia who are seeking thoughtful, physician-led neurotherapy as part of their care.
Dr. Suruchi Chandra is:
Our clinic offers:
Neurotherapy is offered both as part of comprehensive integrative care and as a standalone treatment option for patients pursuing other supportive or medical treatments with clinicians elsewhere.
Dr. Suruchi Chandra is:
- A psychiatrist with training in neuroimmune conditions
- BCIA-certified in neurofeedback
- A qEEG diplomate
Our clinic offers:
- qEEG brain mapping
- Neurofeedback (ILF and SCP)
- Transcranial direct current stimulation (tDCS)
- Non-invasive vagus nerve stimulation
Neurotherapy is offered both as part of comprehensive integrative care and as a standalone treatment option for patients pursuing other supportive or medical treatments with clinicians elsewhere.
Why Neurotherapy Makes Sense in ME/CFS
ME/CFS is increasingly understood as a condition of regulatory dysfunction rather than structural damage. The brain and nervous system are not broken; they are stuck in maladaptive patterns shaped by illness, inflammation, and prolonged stress signaling.
Neurotherapy approaches aim to:
This learning-based, regulatory focus is particularly important in ME/CFS, where overly aggressive or stimulating interventions may worsen symptoms.
Neurotherapy approaches aim to:
- Support nervous system flexibility
- Improve communication between brain networks
- Reduce over-activation or under-activation patterns
- Promote stability rather than force change
This learning-based, regulatory focus is particularly important in ME/CFS, where overly aggressive or stimulating interventions may worsen symptoms.
Neurofeedback for ME/CFS: ILF and SCP Approaches
Neurofeedback trains the brain to recognize and adjust its own activity through real-time feedback. In ME/CFS, gentler approaches are often preferred.
Research on neurofeedback in chronic fatigue is limited but suggestive. Clinical experience indicates that some patients experience improvements in cognition, sleep quality, emotional regulation, or resilience when neurofeedback is carefully individualized and paced.
- ILF (Infralow Frequency) neurofeedback targets very slow brain oscillations involved in autonomic regulation, arousal, and stability. Over time, some patients experience improved regulation, calmer baseline states, or greater tolerance for daily demands.
- SCP (Slow Cortical Potential) neurofeedback focuses on improving cortical regulation related to activation and inhibition, which may be relevant for cognitive fatigue, brain fog, and attentional control.
Research on neurofeedback in chronic fatigue is limited but suggestive. Clinical experience indicates that some patients experience improvements in cognition, sleep quality, emotional regulation, or resilience when neurofeedback is carefully individualized and paced.
tDCS and Targeted Neuromodulation
Transcranial direct current stimulation (tDCS) is a non-invasive neuromodulation technique that delivers low-level electrical current to targeted brain regions. In clinical practice, tDCS is most often used to support mood regulation and cognitive engagement, particularly in patients experiencing brain fog, low motivation, or apathy.
In ME/CFS, tDCS may be used to gently stimulate networks involved in mood, attention, and executive functioning. For some patients, this can support clearer thinking, improved emotional tone, and greater capacity to initiate and sustain mental effort. Protocols are individualized and adjusted based on response and tolerance.
In ME/CFS, tDCS may be used to gently stimulate networks involved in mood, attention, and executive functioning. For some patients, this can support clearer thinking, improved emotional tone, and greater capacity to initiate and sustain mental effort. Protocols are individualized and adjusted based on response and tolerance.
Sleep Disturbance, Anxiety, and Depression in ME/CFS
Sleep disruption is nearly universal in ME/CFS. Many patients report difficulty falling or staying asleep, non-restorative sleep, or a mismatch between time slept and daytime energy.
Anxiety and depression are also common. In the context of ME/CFS, these symptoms are best understood not as primary psychiatric causes, but as neurobiological consequences of chronic illness, inflammation, autonomic imbalance, and prolonged stress on the nervous system. When present, they significantly affect quality of life and often interact with fatigue, cognition, and pain.
Anxiety and depression are also common. In the context of ME/CFS, these symptoms are best understood not as primary psychiatric causes, but as neurobiological consequences of chronic illness, inflammation, autonomic imbalance, and prolonged stress on the nervous system. When present, they significantly affect quality of life and often interact with fatigue, cognition, and pain.
Vagus Nerve Stimulation and Autonomic Regulation
The vagus nerve plays a central role in communication between the brain, immune system, and body. Research suggests that vagal signaling influences inflammation, stress responses, and energy regulation—processes highly relevant to ME/CFS.
Non-invasive vagus nerve stimulation is being studied as a way to:
For some patients, vagus nerve stimulation may complement neurofeedback and integrative medical care by supporting autonomic balance and recovery capacity.
Non-invasive vagus nerve stimulation is being studied as a way to:
- Support parasympathetic activity
- Modulate inflammatory signaling
- Improve fatigue and stress tolerance
For some patients, vagus nerve stimulation may complement neurofeedback and integrative medical care by supporting autonomic balance and recovery capacity.
What Neurotherapy Can—and Cannot—Do in ME/CFS
Neurotherapy is not a cure for ME/CFS, and it is not a replacement for medical evaluation or integrative treatment. It is best understood as a supportive intervention that may help:
Not every patient responds, and progress is often gradual. Careful pacing, monitoring, and individualization are essential.
- Improve brain regulation and cognitive clarity
- Support sleep and emotional resilience
- Reduce nervous system reactivity
- Enhance recovery when patients plateau with standard care
Not every patient responds, and progress is often gradual. Careful pacing, monitoring, and individualization are essential.
Brain Fog, Cognition, and Mental Fatigue in ME/CFS
Cognitive dysfunction—often described as brain fog—is among the most commonly reported and most disruptive symptoms of ME/CFS. Patients may experience:
These symptoms often fluctuate and worsen with exertion, stress, or poor sleep. They are not explained by lack of effort or motivation. Rather, neurocognitive difficulties in ME/CFS reflect functional changes in brain network regulation, particularly in systems involved in attention, working memory, and information integration.
- Slowed information processing
- Difficulty concentrating or multitasking
- Word-finding problems
- Mental exhaustion after brief cognitive effort
These symptoms often fluctuate and worsen with exertion, stress, or poor sleep. They are not explained by lack of effort or motivation. Rather, neurocognitive difficulties in ME/CFS reflect functional changes in brain network regulation, particularly in systems involved in attention, working memory, and information integration.
For many people with myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) and related conditions, the most disabling symptoms extend beyond physical exhaustion alone. Brain fog, slowed thinking, non-restorative sleep, anxiety, depression, and heightened sensitivity to stress often become central features of the illness.
These symptoms are not incidental. A growing body of evidence suggests that ME/CFS involves measurable changes in brain function and nervous system regulation, even when structural imaging such as MRI appears normal. Neurotherapy offers a way to better understand these changes and, for some patients, to support recovery by improving regulation within affected brain and autonomic networks.
This article focuses specifically on the brain and nervous system effects of ME/CFS, and how qEEG-guided neurotherapy approaches may help address cognitive, emotional, and sleep-related symptoms.
These symptoms are not incidental. A growing body of evidence suggests that ME/CFS involves measurable changes in brain function and nervous system regulation, even when structural imaging such as MRI appears normal. Neurotherapy offers a way to better understand these changes and, for some patients, to support recovery by improving regulation within affected brain and autonomic networks.
This article focuses specifically on the brain and nervous system effects of ME/CFS, and how qEEG-guided neurotherapy approaches may help address cognitive, emotional, and sleep-related symptoms.
Understanding Brain Symptoms and Supporting Recovery Through Nervous System Regulation
